4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001209191-22-031791
Director bought 205,000 shares at an average $3.47 ($711,700)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fletcher Aaron G.L. Director | 2022-05-23 | Purchase | +150,000 | $3.52 | $528,000 | 885,000 | I: show line 1 in the form |
| Fletcher Aaron G.L. Director | 2022-05-24 | Purchase | +55,000 | $3.34 | $183,700 | 940,000 | I: show line 2 in the form |
| Open-market purchases · 205,000 sh · avg $3.47 · $711,700 | |||||||
Loading xslF345X03/doc4.xml…